Can early effective anticoagulation prevent new lesions on magnetic resonance imaging in acute cardioembolic stroke?

Journal of Stroke and Cerebrovascular Diseases

Volumn 23, Issue 8, 2014, Pages 2099-2104

  Nomura, Eiichi ^a   Ohshita, Tomohiko ^a   Imamura, Eiji ^a   Wakabayashi, Shinichi ^a   Kajikawa, Hiroshi ^a   Matsumoto, Masayasu ^b  

^a Suiseikai Kajikawa Hospital   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Acute ischemic stroke; atrial fibrillation; diffusion weighted magnetic resonance imaging; prothrombin time and international normalized ratio; warfarin

Indexed keywords

CREATININE; HEPARIN; WARFARIN; ANTICOAGULANT AGENT; PROTHROMBIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIFFUSION WEIGHTED IMAGING; DYSLIPIDEMIA; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTHROMBIN TIME; SEVERE RENAL IMPAIRMENT; STROKE PATIENT; AGED; ATRIAL FIBRILLATION; HOSPITALIZATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; STANDARDS; STROKE; TIME; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HEPARIN; HOSPITALIZATION; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PROTHROMBIN; STROKE; TIME FACTORS; TREATMENT OUTCOME; WARFARIN;

EID: 84908220758     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2014.03.016     Document Type: Article

References (21)

1. A. Arboix, and J. Alió Cardioembolic stroke: clinical features, specific cardiac disorders and prognosis Curr Cardiol Rev 6 2010 150 161
2. M. Paciaroni, G. Agnelli, and S. Micheli Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials Stroke 38 2007 423 430
3. L.C. Guedes, and J.M. Ferro A systematic review of immediate anticoagulation for ischemic stroke of presumed cardioembolic origin Stroke 39 2008 e81 e82
4. S. Micheli, G. Agnelli, and V. Caso Clinical benefit of early anticoagulation in cardioembolic stroke Cerebrovasc Dis 25 2008 289 296
5. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke EAFT (European Atrial Fibrillation Trial) Study Group Lancet 342 1993 1255 1262
6. A. D'Angelo, P. Della Valle, and L. Crippa Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment Haematologica 87 2002 1074 1080
7. H. Hallevi, K.C. Albright, and S. Martin-Schild Anticoagulation after cardioembolic stroke: to bridge or not to bridge? Arch Neurol 65 2008 1169 1173
8. K.A. Bauer Pros and cons of new oral anticoagulants Hematology Am Soc Hematol Educ Program 2013 2013 464 470
9. K. Shibazaki, K. Kimura, and J. Aoki Early initiation of new oral anticoagulants in acute stroke and TIA patients with nonvalvular atrial fibrillation J Neurol Sci 331 2013 90 93
10. D.W. Kang, S.U. Lattimore, and L.L. Latour Silent ischemic lesion recurrence on magnetic resonance imaging predicts subsequent clinical vascular events Arch Neurol 63 2006 1730 1733
11. W.J. Kim, J.H. Kim, and Y. Ko Can early ischemic lesion recurrence on diffusion-weighted MRI affect functional outcome after acute ischemic stroke? J Clin Neurol 6 2010 19 26
12. C.H. Nolte, F.N. Albach, and P.U. Heuschmann Silent new DWI lesions within the first week after stroke Cerebrovasc Dis 33 2012 248 254
13. M. Yasaka, K. Minematsu, and T. Yamaguchi Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation Intern Med 40 2001 1183 1188
14. P.K. Maccallum, R. Mathur, and S.A. Hull Patient safety and estimation of renal function in patients prescribed new oral anticoagulants for stroke prevention in atrial fibrillation: a cross-sectional study BMJ Open 3 2013 e003343
15. E. Berge, M. Abdelnoor, and P.H. Nakstad Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial Lancet 355 2000 1205 1210
16. R. Saxena, S. Lewis, and E. Berge Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial Stroke 32 2001 2333 2337
17. E.C. Jauch, J.L. Saver, and H.P. Adams Jr. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 44 2013 870 947
18. U. Harbrecht Old and new anticoagulants Hamostaseologie 31 2011 21 27
19. M. Wakita, M. Yasaka, and K. Minematsu Effects of anticoagulation on infarct size and clinical outcome in acute cardioembolic stroke Angiology 53 2002 551 556
20. E.M. Hylek, A.S. Go, and Y. Chang Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation N Engl J Med 349 2003 1019 1026
21. H.J. Audebert, B. Schenk, and V. Tietz Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment Cerebrovasc Dis 26 2008 171 177